The North America wound dressing market is expected to grow from US$ 4,271.81 million in 2022 to US$ 6,210.28 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.
An increase in chronic diseases, such as diabetes, cancer, and other autoimmune disorders, is burdening the healthcare system across the region. Chronic diseases directly impact the body's natural ability to heal. Diabetes and immunodeficiency conditions are among the most detrimental conditions that can slow wound repair. Diabetes is the chronic disease most identified and associated as a risk factor for hospital-acquired and facility pressure injuries. Diabetes impacts the immune system, making infections more common and complicating wound healing. It is one of the most significant global health emergencies of the 21st century. The prolonged healing process due to chronic diseases leads to a long-term need for wound dressings, resulting in high demand for them. Moreover, the increased prevalence of cancer has fueled the number of interventions performed. As a result, wound dressings are used more often to prevent postoperative wound infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudate that requires frequent management. Advanced wound dressings, such as hydrogels, alginates, and foams, help with wound management and infection prevention. As a result, the rise in the incidence of chronic diseases is adding to the demand for wound care products, driving the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America wound dressing market. The North America wound dressing market is expected to grow at a good CAGR during the forecast period.
North America Wound Dressing Market Revenue and Forecast to 2028 (US$ Million)
North America Wound Dressing Market Segmentation
The North America wound dressing market is segmented based on type, application, end user, and country. Based on wound dressing type, the North America wound dressing market is bifurcated into advanced wound dressing and traditional wound dressing. The advanced wound dressing segment dominated the market in 2022. The advanced wound dressing is further segmented into foam dressings, superabsorbent dressings, film dressings, hydrocolloid dressings, wound contact layers, collagen dressings, and others. The traditional wound dressing segment is subsegmented into dry dressings, surgical tapes, and anti-infective dressings. Based on application, the North America wound dressing market is bifurcated into chronic wound and acute wound. The chronic wound segment dominated the market in 2022. The chronic wound segment is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and other chronic wounds. Similarly, the acute wound segment is bifurcated into surgical and traumatic wounds and burns wounds. Based on end user, the North America wound dressing market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The ambulatory surgical centers segment dominated the market in 2022. Based on country, the North America wound dressing market has been categorized into the US, Canada, and Mexico. The US dominated the market in 2022.
3M; Advancis Medical; Axio Biosolutions Pvt Ltd; Coloplast Corp; Convatec Inc.; Integra LifeSciences Holdings Corporation; Medline Industries, Inc.; Medtronic; Mölnlycke Health Care AB.; and Smith+Nephew are among the leading companies in the North America wound dressing market.